0001225208-24-000108.txt : 20240102
0001225208-24-000108.hdr.sgml : 20240102
20240102203127
ACCESSION NUMBER: 0001225208-24-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahoney Michael F
CENTRAL INDEX KEY: 0001533022
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 24504124
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0508
4
2024-01-01
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001533022
Mahoney Michael F
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
1
Chairman, President & CEO
0
Common Stock
2024-01-01
4
M
0
95919.0000
0.0000
A
1594841.0000
D
Common Stock
2024-01-01
4
F
0
40104.0000
57.8100
D
1554737.0000
D
Common Stock
176245.0000
I
By Trust
Performance Share Units
2024-01-01
4
M
0
95919.0000
0.0000
D
2023-12-31
2023-12-31
Common Stock
95919.0000
0.0000
D
On February 17, 2021, the reporting person was awarded a target number of performance share units under the Company's 2021 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's 2021 adjusted free cash flow measured against its 2021 financial plan over the one-year performance period ending December 31, 2021 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2022, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon completion of the individual service period that ended on December 31, 2023.
Each performance shares unit represents the Company's commitment to issue one share of Boston Scientific common stock.
/s/ Susan Thompson, Attorney-in-Fact
2024-01-02